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Development of cardiovascular implantable electronic
devices ―A history of trouble shooting
More than 50 years have passed since the ﬁrst permanent
cardiac pacemaker was implanted in 1958 by Dr. Senning and
colleagues. How much closer are we now to developing a perfect
pacemaker device? Multiple difﬁculties have been overcome,
while many others are still to be addressed. Thus, the history
of the pacemaker is a history of troubleshooting. In this ﬁrst of
two special issues that the Journal of Arrhythmia has dedicated
to pacemaker therapy, current problems of the pacemaker system
will be discussed.
Advances in pacemaker lead technology and implantation
technique are of key importance. Dr. Yuji Nakazato overviews
the history of pacing leads. Before the development of screw-in
leads, a high incidence of dislodgement was a major concern, and
it still remains a routine complication. In particular, the right atrial
appendage is the only feasible ﬁxation position for non-screw
leads in atrial pacing, a problem that may be resolved with the
introduction of the screw-in lead. In this issue, Dr. Shumpei Mori
and colleagues describe a technique for lead insertion in the
inferior interatrial septum via a 9.0 Fr guiding catheter.
High-voltage (HV) short circuit is a leading cause of implan-
table cardioverter-deﬁbrillator (ICD) lead failures. A basic research
paper contributed by Dr. Nakajima and colleagues concludes that
the right ventricular (RV) ring conductor is not related to HV short
circuits even if the RV ring and/or RV ring conductor are placed in
contact with any part of the HV circuit. Instead, it is more likely
that the short circuit occurs in the pocket or inside the lead
between the connector and the SCV coil. Of note, the problem of
aging leads, which have a high potential for insulation failure, is
gaining importance in light of the rapidly increasing number of
ICD implantations. At present, there is no clear managing strategy
for these failure-prone leads. In this issue, Dr. Naoki Hirata and
colleagues report a case of shock-induced failure of a Riata lead
with normal electrical lead parameters and a normal ﬂuoroscopic
appearance. Another case study by Dr. Jayaprakash Shentha
and colleagues describes a Riata lead failure presenting as a life-
threatening electrical storm.
Although in the modern medical practice pacemaker implanta-
tion is usually performed by physicians, it remains a surgical matter.
In spite of known advantages of subcutaneous prepectoral implanta-
tion, lean or physically small patients can suffer from pocket erosion.
To minimize such traumatic complications, prepectoral subfascial
implantation has been employed. Dr. Katsuhiko Imai introduces
a method for prepectoral subfascial pocket creation, whereas
Dr. Masatsugu Nozoe and colleagues report on how thoracoscopic
phrenic nerve insulation using a Gore-Tex patch can help avoid
phrenic nerve stimulation with cardiac resynchronization therapy.
Atrial ﬁbrillation (AF) is observed in almost half of patients
with implanted pacemakers, presenting a great problem in terms
of high incidence of cerebral infarction. Many clinical trials have
demonstrated the effectiveness of atrial pacing with respect to AF
prevention. Although an atrial pacing algorithm for preventing AF
has been developed, the actual effectiveness of AF suppression via
atrial pacing remains unclear. Dr. Toshiko Nakai and colleagues
review this issue.
Efﬁciency of AF detection presents another point of concern [1].
AF is usually identiﬁed by implanted cardiac devices as atrial high
rate episodes (AHRE). However, pacemaker-induced arrhythmias
are also detected as AHRE. Far-ﬁeld R-wave oversensing and
pacemaker-induced arrhythmias, including pacemaker-mediated
tachycardia and repetitive non-reentrant ventriculo-atrial syn-
chrony (RNRVAS), are the two main reasons for atrial oversensing.
The presence of ventriculo-atrial conduction is required for both
types of pacemaker-induced arrhythmias. The incidence of
RNRVAS can increase with the use of various device settings and
functions, such as long atrioventricular (AV) interval program-
ming, the rate-adaptive mode, and the atrial overdrive pacing
algorithm. The negative aspects of pacemaker-induced arrhyth-
mias include loss of optimal AV delay, inappropriate increase in
ventricular pacing, induction of atrial arrhythmias, and inaccurate
diagnosis of AHRE. Dr. Ritsuko Kono and colleagues review the
incidence of arrhythmias, their electrophysiological mechanisms,
and the clinical diagnosis of RNRVAS by using dual-chamber
implantable cardiac devices, whereas a case study by Dr. Takeshi
Kitamura demonstrates that automatic switching between AAI and
DDD modes can prevent RNRVAS.
Bradycardia is not the only indication for cardiac pacing [2]. In
this issue, Dr. Taiju Matsui and colleges report a case of hyper-
trophic obstructive cardiomyopathy in which pacing resulted in
left ventricular remodeling, whereas reverse remodeling was
observed after turning pacing off.
The effect of cardiac pacing on sleep-disordered breathing is
controversial. New insight can be gained from the study of long-
term effects of cardiac pacing on sleep disordered breathing in
patients with conventional indications for permanent pacemakers
by Dr. Kohei Matsushita and colleagues. They conclude that long-
term pacing signiﬁcantly reduces the number of episodes of sleep
apnea in such patients.
Reduced quality of life (QOL) is a major problem in ICD patients.
Dr. Sayaka Kobayash reports on the incidence and risk factors of
post-traumatic stress disorder (PTSD) and assesses its impact on
psychosocial distress and health-related QOL in Japanese patients
with ICD.
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Although clinical utility of magnetic resonance imaging (MRI)
has been widely recognized, imaging of patients with implanted
devices was contraindicated for a long time [3]. Recently, MRI
conditional pacemakers and ICDs have become available. In this
issue, Dr. Yosuke Miwa and colleagues report a case where MRI
was utilized for diagnosis of cardiac sarcoidosis in a patient with
an implanted pacemaker.
In conclusion, a number of challenges have complicated the
development and improvement of the cardiac pacemaker. Has this
device been reﬁned to perfection? Unfortunately, the answer is
currently “no.” However, its evolution will continue.
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